CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.

Saved in:
Bibliographic Details
Title: CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
Authors: Ben-Zimra M; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Niazov S; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Rahimli Alekberli F; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel, francescal@ekmd.huji.ac.il.
Source: International archives of allergy and immunology [Int Arch Allergy Immunol] 2026 Mar 23, pp. 1-6. Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 9211652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0097 (Electronic) Linking ISSN: 10182438 NLM ISO Abbreviation: Int Arch Allergy Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41871214
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ben-Zimra+M%22">Ben-Zimra M</searchLink>; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Niazov+S%22">Niazov S</searchLink>; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Rahimli+Alekberli+F%22">Rahimli Alekberli F</searchLink>; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Levi-Schaffer+F%22">Levi-Schaffer F</searchLink>; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel, francescal@ekmd.huji.ac.il.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229211652%22">International archives of allergy and immunology</searchLink> [Int Arch Allergy Immunol] 2026 Mar 23, pp. 1-6. <i>Date of Electronic Publication: </i>2026 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9211652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0097 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210182438%22">10182438 </searchLink><i>NLM ISO Abbreviation: </i>Int Arch Allergy Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41871214
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000551604
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ben-Zimra M
      – PersonEntity:
          Name:
            NameFull: Niazov S
      – PersonEntity:
          Name:
            NameFull: Rahimli Alekberli F
      – PersonEntity:
          Name:
            NameFull: Levi-Schaffer F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2026 Mar 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1423-0097
          Titles:
            – TitleFull: International archives of allergy and immunology
              Type: main
ResultId 1